business

TiumBio reports trial data for head and neck cancer drug

Investing.com · May 31, 2026, 11:37 PM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

CNBC A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China ARY News Erleada: Prostate cancer drug reduces risk of spread and death

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

TiumBio reports trial data for head and neck cancer drug

Also covered by

More in business